BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Armer JM, Ballman KV, McCall L, Armer NC, Sun Y, Udmuangpia T, Hunt KK, Mittendorf EA, Byrd DR, Julian TB, Boughey JC. Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy. Support Care Cancer 2019;27:495-503. [PMID: 29980907 DOI: 10.1007/s00520-018-4334-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Abdo J, Ortman H, Rodriguez N, Tillman R, Riordan EO, Seydel A. Quality of Life Issues Following Breast Cancer Treatment. Surgical Clinics of North America 2023;103:155-167. [DOI: 10.1016/j.suc.2022.08.014] [Reference Citation Analysis]
2 Lin Q, Yang T, Yongmei J, Die YM. Prediction models for breast cancer-related lymphedema: a systematic review and critical appraisal. Syst Rev 2022;11:217. [PMID: 36229876 DOI: 10.1186/s13643-022-02084-2] [Reference Citation Analysis]
3 Qu FL, Lin CJ, Liu ZB, Cao AY, Wu J, Liu GY, Yu KD, Di GH, Li JJ, Shao ZM. Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe? Breast Cancer Res Treat 2022. [PMID: 36040640 DOI: 10.1007/s10549-022-06708-y] [Reference Citation Analysis]
4 Ochalek K, Gradalski T. Early Detection of Breast Cancer-Related Lymphedema in COVID-19 Pandemic. Lymphat Res Biol 2022. [PMID: 35833890 DOI: 10.1089/lrb.2021.0077] [Reference Citation Analysis]
5 Montagna G, Zhang J, Sevilimedu V, Charyn J, Abbate K, Gomez EA, Mehrara B, Morrow M, Barrio AV. Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema. JAMA Oncol 2022. [PMID: 35679026 DOI: 10.1001/jamaoncol.2022.1628] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Schaverien MV, Dayan JH. Key Topic: Evaluating Outcomes of Lymphedema Surgery. Multimodal Management of Upper and Lower Extremity Lymphedema 2022. [DOI: 10.1007/978-3-030-93039-4_25] [Reference Citation Analysis]
7 tidhar D, Armer JM, Anbari AB, Sun Y, Bernas M, Feldman JL. Clinical Evaluation of Lymphedema. Principles and Practice of Lymphedema Surgery 2022. [DOI: 10.1016/b978-0-323-69418-6.00009-3] [Reference Citation Analysis]
8 Corsi F, Albasini S, Sorrentino L, Armatura G, Carolla C, Chiappa C, Combi F, Curcio A, Della Valle A, Ferrari G, Gasparri ML, Gentilini O, Ghilli M, Listorti C, Mancini S, Marinello P, Meani F, Mele S, Pertusati A, Roncella M, Rovera F, Sgarella A, Tazzioli G, Tognali D, Folli S. Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients. Breast 2021;60:131-7. [PMID: 34624755 DOI: 10.1016/j.breast.2021.09.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Kassamani YW, Brunelle CL, Gillespie TC, Bernstein MC, Bucci LK, Nassif T, Taghian AG. Diagnostic Criteria for Breast Cancer-Related Lymphedema of the Upper Extremity: The Need for Universal Agreement. Ann Surg Oncol 2021. [PMID: 34505218 DOI: 10.1245/s10434-021-10645-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Jørgensen MG, Toyserkani NM, Hansen FG, Bygum A, Sørensen JA. The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment. NPJ Breast Cancer 2021;7:70. [PMID: 34075045 DOI: 10.1038/s41523-021-00276-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
11 Fozza A, Giaj-Levra N, De Rose F, Ippolito E, Silipigni S, Meduri B, Fiorentino A, Gregucci F, Marino L, Di Grazia A, Cucciarelli F, Borghesi S, De Santis MC, Ciabattoni A. Lymph nodal radiotherapy in breast cancer: what are the unresolved issues? Expert Rev Anticancer Ther 2021;21:827-40. [PMID: 33852379 DOI: 10.1080/14737140.2021.1917390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Baran E, Yildiz Tİ, Gursen C, Üzelpasaci E, Özgül S, Düzgün İ, Akbayrak T. The association of breast cancer-related lymphedema after unilateral mastectomy with shoulder girdle kinematics and upper extremity function. J Biomech 2021;121:110432. [PMID: 33887538 DOI: 10.1016/j.jbiomech.2021.110432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Gursen C, Dylke ES, Moloney N, Meeus M, De Vrieze T, Devoogdt N, De Groef A. Self-reported signs and symptoms of secondary upper limb lymphoedema related to breast cancer treatment: Systematic review. Eur J Cancer Care (Engl) 2021;:e13440. [PMID: 33733550 DOI: 10.1111/ecc.13440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Havens LM, Brunelle CL, Gillespie TC, Bernstein M, Bucci LK, Kassamani YW, Taghian AG. Use of technology to facilitate a prospective surveillance program for breast cancer-related lymphedema at the Massachusetts General Hospital. Mhealth 2021;7:11. [PMID: 33634194 DOI: 10.21037/mhealth-19-218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Alsharif F, Almutairi W, Shibily F, Alhothari F, Batwa F, Batwa N, Alharbi L. The Level of Lymphedema Awareness among Women with Breast Cancer in the Kingdom of Saudi Arabia. Int J Environ Res Public Health 2021;18:E627. [PMID: 33450971 DOI: 10.3390/ijerph18020627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Brunelle CL, Roberts SA, Horick NK, Gillespie TC, Jacobs JM, Daniell KM, Naoum GE, Taghian AG. Integrating Symptoms Into the Diagnostic Criteria for Breast Cancer-Related Lymphedema: Applying Results From a Prospective Surveillance Program. Phys Ther 2020;100:2186-97. [PMID: 32931555 DOI: 10.1093/ptj/pzaa162] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
17 Ozturk CN, Schwarz G, Gurunian R. Lymphovenous Bypass and Lymphoid Tissue Transfer. Breast Cancer Essentials 2021. [DOI: 10.1007/978-3-030-73147-2_45] [Reference Citation Analysis]
18 McLaughlin SA, Stout NL, Schaverien MV. Avoiding the Swell: Advances in Lymphedema Prevention, Detection, and Management. Am Soc Clin Oncol Educ Book 2020;40:1-10. [PMID: 32315238 DOI: 10.1200/EDBK_280471] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
19 Shah C, Zambelli-Weiner A, Delgado N, Sier A, Bauserman R, Nelms J. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements. Breast Cancer Res Treat 2021;185:709-40. [PMID: 33245458 DOI: 10.1007/s10549-020-05988-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
20 White BN, Lu IM, Kao LS, Dixon JB, Weiler MJ, Frank ND, Binkley J, Subhedar P, Okoli J, Buhariwalla K, Suarez-Ligon A, Gabram-Mendola SGA. An infrared 3D scanning device as a novel limb volume measurement tool in breast cancer patients. World J Surg Oncol 2020;18:278. [PMID: 33109204 DOI: 10.1186/s12957-020-02043-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Paskett ED, Le-Rademacher J, Oliveri JM, Liu H, Seisler DK, Sloan JA, Armer JM, Naughton MJ, Hock K, Schwartz M, Unzeitig G, Melnik M, Yee LD, Fleming GF, Taylor JR, Loprinzi C. A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance). Cancer 2021;127:291-9. [PMID: 33079411 DOI: 10.1002/cncr.33183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
22 Tánori-Tapia JM, Romero-Pérez EM, Camberos NA, Horta-Gim MA, Núñez-Othón G, Medina-Pérez C, de Paz JA. Determination of the Minimum Detectable Change in the Total and Segmental Volumes of the Upper Limb, Evaluated by Perimeter Measurements. Healthcare (Basel) 2020;8:E285. [PMID: 32825744 DOI: 10.3390/healthcare8030285] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Aldrich MB, Rasmussen JC, Fife CE, Shaitelman SF, Sevick-Muraca EM. The Development and Treatment of Lymphatic Dysfunction in Cancer Patients and Survivors. Cancers (Basel) 2020;12:E2280. [PMID: 32823928 DOI: 10.3390/cancers12082280] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
24 Armer JM, Ballman KV, McCall L, Ostby PL, Zagar E, Kuerer HM, Hunt KK, Boughey JC. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection. JAMA Surg 2019;154:800-9. [PMID: 31314062 DOI: 10.1001/jamasurg.2019.1742] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
25 de Campos Souza PV, Wang Y, Lughofer E. Knowledge extraction about patients surviving breast cancer treatment through an autonomous fuzzy neural network. 2020 IEEE International Conference on Fuzzy Systems (FUZZ-IEEE) 2020. [DOI: 10.1109/fuzz48607.2020.9177561] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Torgbenu E, Luckett T, Buhagiar MA, Chang S, Phillips JL. Prevalence and incidence of cancer related lymphedema in low and middle-income countries: a systematic review and meta-analysis. BMC Cancer 2020;20:604. [PMID: 32600278 DOI: 10.1186/s12885-020-07079-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
27 Bundred N, Foden P, Todd C, Morris J, Watterson D, Purushotham A, Bramley M, Riches K, Hodgkiss T, Evans A, Skene A, Keeley V; Investigators of BEA/PLACE studies. Increases in arm volume predict lymphoedema and quality of life deficits after axillary surgery: a prospective cohort study. Br J Cancer 2020;123:17-25. [PMID: 32362658 DOI: 10.1038/s41416-020-0844-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
28 Flores AM, Nelson J, Sowles L, Stephenson RG, Robinson K, Cheville A, Sander AP, Blot WJ. Lymphedema Signs, Symptoms, and Diagnosis in Women Who Are in Minority and Low-Income Groups and Have Survived Breast Cancer. Phys Ther 2020;100:487-99. [PMID: 32031628 DOI: 10.1093/ptj/pzaa002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Coriddi M, Dayan J, Sobti N, Nash D, Goldberg J, Klassen A, Pusic A, Mehrara B. Systematic Review of Patient-Reported Outcomes following Surgical Treatment of Lymphedema. Cancers (Basel) 2020;12:E565. [PMID: 32121343 DOI: 10.3390/cancers12030565] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
30 He L, Qu H, Wu Q, Song Y. Lymphedema in survivors of breast cancer. Oncol Lett 2020;19:2085-96. [PMID: 32194706 DOI: 10.3892/ol.2020.11307] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]